Sign up to save your podcasts
Or
Share Optimizing outcomes in advanced endometrial carcinoma: Navigating guidelines, biomarker-driven immunotherapy and irAE management
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Optimizing outcomes in advanced endometrial carcinoma: Navigating guidelines, biomarker-driven immunotherapy and irAE management
touchCASES for touchONCOLOGY
Join two international experts as they walk through three real-world patient stories, showing how molecular testing shapes treatment choices in advanced endometrial cancer and how immune-related side effects can be recognized and managed in everyday practice.
The experts:
This activity is supported by an independent educational grant from Merck Sharp & Dohme LLC.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: www.touchONCOLOGY.com
View all episodes
By touchpodcasttouchCASES for touchONCOLOGY
Join two international experts as they walk through three real-world patient stories, showing how molecular testing shapes treatment choices in advanced endometrial cancer and how immune-related side effects can be recognized and managed in everyday practice.
The experts:
This activity is supported by an independent educational grant from Merck Sharp & Dohme LLC.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: www.touchONCOLOGY.com